|
[1]
|
Tanaka, A., Ma, X., Yokosuka, O., et al. (2016) Autoimmune Liver Diseases in the Asia-Pacific Region: Proceedings of APASL Symposium on AIH and PBC 2016. Hepatology International, 10, 909-915. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Aabakken, L., Karlsen, T.H., Albert, J., et al. (2017) Role of Endoscopy in Primary Sclerosing Cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Journal of Hepatology, 66, 1265-1281. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Aabakken, L., Karlsen, T., Albert, J., et al. (2017) Role of Endoscopy in Primary Sclerosing Cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy, 49, 588-608. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Liu, H., Liu, Y., Wang, L., et al. (2010) Prevalence of Primary Biliary Cirrhosis in Adults Referring Hospital for Annual Health Check-Up in Southern China. BMC Gastroenterology, 10, Article No. 100. [Google Scholar] [CrossRef]
|
|
[5]
|
Lindor, K.D., Bowlus, C.L., Boyer, J., et al. (2018) Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology, 69, 394-419. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Dong, M., Li, J., Tang, R., et al. (2015) Multiple Genetic Variants Associated with Primary Biliary Cirrhosis in a Han Chinese Population. Clinical Reviews in Allergy & Immunology, 48, 316-321. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Lleo, A., Leung, P.S.C., Hirschfield, G.M., et al. (2019) The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review. Seminars in Liver Disease, 40, 34-48. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Hirschfield, G.M., Dyson, J.K., Alexander, G.J.M., et al. (2018) The British Society of Gastroenterology/UK-PBC Primary Biliary Cholangitis Treatment and Management Guidelines. Gut, 67, 1568-1594. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ludwig, J., Dickson, E.R., Mcdonald, G.S.A., et al. (1978) Staging of Chronic Nonsuppurative Destructive Cholangitis (Syndrome of Primary Biliary Cirrhosis). Virchows Archiv A, 379, 103-112. [Google Scholar] [CrossRef]
|
|
[10]
|
Zhang, J.L., Si, H.F., Zhou, X.Z., et al. (2019) High Prevalence of Fasciolosis and Evaluation of the Efficacy of Anthelmintics against Fasciola hepatica in Buffaloes in Guangxi, China. International Journal for Parasitology: Parasites and Wildlife, 8, 82-87. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Yang, F., Tang, X., Ding, L., et al. (2016) Curcumin Protects ANIT-Induced Cholestasis through Signaling Pathway of FXR-Regulated Bile Acid and Inflammation. Scientific Reports, 6, Article No. 33052. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Yang, F., Yang, Y., Wang, Q., et al. (2017) The Risk Predictive Values of UK-PBC and GLOBE Scoring System in Chinese Patients with Primary Biliary Cholangitis: The Additional Effect of Anti-gp210. Alimentary Pharmacology & Therapeutics, 45, 733-743. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Sun, L., Wang, Y., Liu, Y., et al. (2015) Differential Characteristics of AMA-M2 Autoantibody in Primary Biliary Cirrhosis and Non-PBC Patients. Chinese Journal of Hepatology, 23, 343-349.
|
|
[14]
|
Heathcote, E.J. (2000) Management of Primary Biliary Cirrhosis. Hepatology, 31, 1005-1013. [Google Scholar] [CrossRef] [PubMed]
|